-
Something wrong with this record ?
MRSA surveillance programmes worldwide: moving towards a harmonised international approach
VO. Baede, MZ. David, AT. Andrasevic, DS. Blanc, M. Borg, G. Brennan, B. Catry, A. Chabaud, J. Empel, H. Enger, M. Hallin, M. Ivanova, A. Kronenberg, K. Kuntaman, AR. Larsen, K. Latour, JA. Lindsay, B. Pichon, D. Santosaningsih, LM. Schouls, F....
Language English Country Netherlands
Document type Journal Article
- MeSH
- Anti-Bacterial Agents pharmacology therapeutic use MeSH
- Epidemiological Monitoring MeSH
- Soft Tissue Infections * drug therapy MeSH
- Humans MeSH
- Methicillin-Resistant Staphylococcus aureus * MeSH
- Staphylococcal Infections * drug therapy MeSH
- Check Tag
- Humans MeSH
- Publication type
- Journal Article MeSH
Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and to propose a framework for harmonisation of MRSA surveillance. The International Society of Antimicrobial Chemotherapy (ISAC) MRSA Working Group conducted a structured survey on MRSA surveillance programmes and organised a webinar to discuss the programmes' strengths and challenges as well as guidelines for harmonisation. Completed surveys represented 24 MRSA surveillance programmes in 16 countries. Several countries reported separate epidemiological and microbiological surveillance. Informing clinicians and national policy-makers were the most common purposes of surveillance. Surveillance of bloodstream infections (BSIs) was present in all programmes. Other invasive infections were often included. Three countries reported active surveillance of MRSA carriage. Methodology and reporting of antimicrobial susceptibility, virulence factors, molecular genotyping and epidemiological metadata varied greatly. Current MRSA surveillance programmes rely upon heterogeneous data collection systems, which hampers international epidemiological monitoring and research. To harmonise MRSA surveillance, we suggest improving the integration of microbiological and epidemiological data, implementation of central biobanks for MRSA isolate collection, and inclusion of a representative sample of skin and soft-tissue infection cases in addition to all BSI cases.
Department of Epidemiology and Clinical Microbiology National Medicines Institute Warsaw Poland
Department of Infection Control Mater Dei Hospital Msida Malta
Department of Medical Microbiology Faculty of Medicine Universitas Airlangga Surabaya Indonesia
Department of Medicine University of Pennsylvania Philadelphia Pennsylvania USA
Department of Microbiology LHUB ULB Université Libre de Bruxelles Brussels Belgium
Dr Soetomo General Academic Hospital Surabaya Indonesia
East Tallinn Central Hospital Laboratory Tallinn Estonia
Faculty of Medicine Université libre de Bruxelles Brussels Belgium
Healthcare associated infections and antimicrobial resistance Sciensano Brussels Belgium
Institute for Infection and Immunity St George's University of London London UK
Institute for Medical Microbiology Immunology and Hygiene University of Cologne Köln Germany
Mission nationale SPARES Limoges University Hospital Limoges France
National Infection Service Public Health England London UK
National MRSA Reference Laboratory St James's Hospital Dublin 8 Ireland
The Norwegian MRSA Reference Laboratory St Olavs Hospital Trondheim Norway
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22010862
- 003
- CZ-PrNML
- 005
- 20220506130233.0
- 007
- ta
- 008
- 220425s2022 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.ijantimicag.2022.106538 $2 doi
- 035 __
- $a (PubMed)35091055
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Baede, Valérie O $u Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands
- 245 10
- $a MRSA surveillance programmes worldwide: moving towards a harmonised international approach / $c VO. Baede, MZ. David, AT. Andrasevic, DS. Blanc, M. Borg, G. Brennan, B. Catry, A. Chabaud, J. Empel, H. Enger, M. Hallin, M. Ivanova, A. Kronenberg, K. Kuntaman, AR. Larsen, K. Latour, JA. Lindsay, B. Pichon, D. Santosaningsih, LM. Schouls, F. Vandenesch, G. Werner, D. Żabicka, H. Žemličková, H. Seifert, MC. Vos, MRSA Surveillance Worldwide Study Group (ISAC), the ESCMID Study Group for Nosocomial Infections (ESGNI), the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS)
- 520 9_
- $a Multinational surveillance programmes for methicillin-resistant Staphylococcus aureus (MRSA) are dependent on national structures for data collection. This study aimed to capture the diversity of national MRSA surveillance programmes and to propose a framework for harmonisation of MRSA surveillance. The International Society of Antimicrobial Chemotherapy (ISAC) MRSA Working Group conducted a structured survey on MRSA surveillance programmes and organised a webinar to discuss the programmes' strengths and challenges as well as guidelines for harmonisation. Completed surveys represented 24 MRSA surveillance programmes in 16 countries. Several countries reported separate epidemiological and microbiological surveillance. Informing clinicians and national policy-makers were the most common purposes of surveillance. Surveillance of bloodstream infections (BSIs) was present in all programmes. Other invasive infections were often included. Three countries reported active surveillance of MRSA carriage. Methodology and reporting of antimicrobial susceptibility, virulence factors, molecular genotyping and epidemiological metadata varied greatly. Current MRSA surveillance programmes rely upon heterogeneous data collection systems, which hampers international epidemiological monitoring and research. To harmonise MRSA surveillance, we suggest improving the integration of microbiological and epidemiological data, implementation of central biobanks for MRSA isolate collection, and inclusion of a representative sample of skin and soft-tissue infection cases in addition to all BSI cases.
- 650 _2
- $a antibakteriální látky $x farmakologie $x terapeutické užití $7 D000900
- 650 _2
- $a epidemiologické monitorování $7 D062665
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a methicilin rezistentní Staphylococcus aureus $7 D055624
- 650 12
- $a infekce měkkých tkání $x farmakoterapie $7 D018461
- 650 12
- $a stafylokokové infekce $x farmakoterapie $7 D013203
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a David, Michael Z $u Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA
- 700 1_
- $a Andrasevic, Arjana Tambic $u Department of Clinical Microbiology, University Hospital for Infectious Diseases, University of Zagreb School of Dental Medicine, Zagreb, Croatia
- 700 1_
- $a Blanc, Dominique S $u Hospital Preventive Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Swiss National Reference Center for Emerging Antibiotic Resistance, Lausanne site, Lausanne, Switzerland
- 700 1_
- $a Borg, Michael $u Department of Infection Control, Mater Dei Hospital, Msida, Malta
- 700 1_
- $a Brennan, Grainne $u National MRSA Reference Laboratory, St James's Hospital, Dublin 8, Ireland
- 700 1_
- $a Catry, Boudewijn $u Healthcare-associated infections & antimicrobial resistance, Sciensano, Brussels, Belgium; Faculty of Medicine, Université libre de Bruxelles, Brussels, Belgium
- 700 1_
- $a Chabaud, Aurélie $u Mission nationale SPARES (Surveillance et Prévention de l'AntibioRésistance en Etablissement de santé), Limoges University Hospital, Limoges, France
- 700 1_
- $a Empel, Joanna $u Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
- 700 1_
- $a Enger, Hege $u The Norwegian MRSA Reference Laboratory, St Olavs Hospital, Trondheim, Norway
- 700 1_
- $a Hallin, Marie $u Department of Microbiology, LHUB-ULB, Université Libre de Bruxelles, Brussels, Belgium
- 700 1_
- $a Ivanova, Marina $u East-Tallinn Central Hospital Laboratory, Tallinn, Estonia
- 700 1_
- $a Kronenberg, Andreas $u Swiss Centre for Antibiotic Resistance, Institute for Infectious Diseases, University of Bern, Bern, Switzerland
- 700 1_
- $a Kuntaman, Kuntaman $u Department of Medical Microbiology, Faculty of Medicine, Universitas Airlangga, Surabaya, Indonesia; Dr Soetomo General Academic Hospital, Surabaya, Indonesia
- 700 1_
- $a Larsen, Anders Rhod $u National Reference Laboratory for Antimicrobial Resistance, Department of Bacteria, Fungi and Parasites, Statens Serum Institut, Copenhagen, Denmark
- 700 1_
- $a Latour, Katrien $u Healthcare-associated infections & antimicrobial resistance, Sciensano, Brussels, Belgium
- 700 1_
- $a Lindsay, Jodi A $u Institute for Infection and Immunity, St George's, University of London, London, UK
- 700 1_
- $a Pichon, Bruno $u National Infection Service, Public Health England, London, UK
- 700 1_
- $a Santosaningsih, Dewi $u Department of Clinical Microbiology, Faculty of Medicine, Brawijaya University/Dr Saiful Anwar Hospital, Malang, Indonesia
- 700 1_
- $a Schouls, Leo M $u Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands
- 700 1_
- $a Vandenesch, François $u Centre International de Recherche en Infectiologie (CIRI), Université de Lyon, INSERM, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France; Centre National de Référence des Staphylocoques, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France
- 700 1_
- $a Werner, Guido $u Robert Koch Institute, Department of Infectious Diseases, National Reference Centre for Staphylococci and Enterococci, Wernigerode Branch, Germany
- 700 1_
- $a Żabicka, Dorota $u Department of Epidemiology and Clinical Microbiology, National Medicines Institute, Warsaw, Poland
- 700 1_
- $a Žemličková, Helena $u National Reference Laboratory for Antibiotics, Centre for Epidemiology and Microbiology, National Institute of Public Health, 10000 Prague, Czech Republic; Department of Microbiology, 3rd Faculty of Medicine Charles University, University Hospital Kralovske Vinohrady and National Institute of Public Health, 10000 Prague, Czech Republic
- 700 1_
- $a Seifert, Harald $u Institute for Medical Microbiology, Immunology and Hygiene, University of Cologne, Köln, Germany
- 700 1_
- $a Vos, Margreet C $u Department of Medical Microbiology and Infectious Diseases, Erasmus MC University Medical Center Rotterdam, Rotterdam, the Netherlands. Electronic address: m.vos@erasmusmc.nl
- 710 2_
- $a MRSA Surveillance Worldwide Study Group (ISAC), the ESCMID Study Group for Nosocomial Infections (ESGNI), the ESCMID Study Group for Staphylococci and Staphylococcal Diseases (ESGS)
- 773 0_
- $w MED00005050 $t International journal of antimicrobial agents $x 1872-7913 $g Roč. 59, č. 3 (2022), s. 106538
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35091055 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220425 $b ABA008
- 991 __
- $a 20220506130225 $b ABA008
- 999 __
- $a ok $b bmc $g 1788800 $s 1162060
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 59 $c 3 $d 106538 $e 20220126 $i 1872-7913 $m International journal of antimicrobial agents $n Int J Antimicrob Agents $x MED00005050
- LZP __
- $a Pubmed-20220425
